ON
← Natrag na feed
Antarktička biljka može pomoći u razvoju novog lijeka protiv melanoma
XK🔬 Znanostprekjučer

Antarktička biljka može pomoći u razvoju novog lijeka protiv melanoma

A study published by researchers from the University of Florida has discovered that toxins produced by a small marine organism known as 'ascidians' or sea squirts living in Antarctica could potentially aid in developing a new treatment for melanoma, one of the deadliest forms of skin cancer. The research, reported by The Guardian, indicates that these toxins have been shown to destroy melanoma cells in laboratory tests without harming healthy cells. Professor Bill Baker, a chemistry expert involved in the study, emphasized that while this is promising, the path to an approved drug is long and requires extensive testing. He noted that recent expeditions to Antarctica provided valuable insights into how bacteria within these organisms produce the toxins, bringing scientists closer to potential treatments. However, challenges remain, including the difficulty of harvesting sufficient quantities of the toxin without damaging the Antarctic ecosystem. Baker also highlighted that over half of approved drugs originate from natural substances, underscoring the significance of such discoveries.

Idi na primarne izvore (1)

Službeni izvori na kojima se izvještavanje temelji. Pročitaj ih izravno da zaobiđeš uokvirivanje.

1 izvještaja

Koha.net logoKoha.netNeovisanSredinaČinjenice 85Objektivnost 75prekjučer
Antarktička biljka može pomoći u razvoju novog lijeka protiv melanoma

A study published by researchers from the University of Florida has discovered that toxins produced by a small marine organism known as 'ascidians' or sea squirts living in Antarctica could potentially aid in developing a new treatment for melanoma, one of the deadliest forms of skin cancer. The research, reported by The Guardian, indicates that these toxins have been shown to destroy melanoma cells in laboratory tests without harming healthy cells. Professor Bill Baker, a chemistry expert involved in the study, emphasized that while this is promising, the path to an approved drug is long and requires extensive testing. He noted that recent expeditions to Antarctica provided valuable insights into how bacteria within these organisms produce the toxins, bringing scientists closer to potential treatments. However, challenges remain, including the difficulty of harvesting sufficient quantities of the toxin without damaging the Antarctic ecosystem. Baker also highlighted that over half of approved drugs originate from natural substances, underscoring the significance of such discoveries.

Procjena pristranosti (Sredina): The article presents scientific findings without overt ideological framing. It focuses on the research process, challenges, and implications of the discovery without taking a partisan stance. The tone remains objective, emphasizing the scientific method and the need for further testing rather than a

Zašto ove ocjene (Činjenice 85 · Objektivnost 75): The article accurately reports the research findings from the primary source, including the use of ascidian toxins against melanoma in mice. However, it slightly simplifies the process and omits details about regulatory trials and the broader implications of the research. The tone is generally neutr

Neka vijesti ostanu poštene.

ObjectiveNews financiraju čitatelji i bez oglasa je – pristranost vam pokazujemo, ne skrivamo. Podržite neovisno novinarstvo za 5 €/mjesec.

Postani podupiratelj

Povezane priče